Literature DB >> 25007090

Medical therapy of sarcoidosis.

Robert P Baughman1, Elyse E Lower1.   

Abstract

For treatment of sarcoidosis, one should develop a long-term management plan. Factors to be considered include the organ involvement and severity of symptoms. Different organ manifestations may require different treatments. Intensity of treatment is usually based on severity of disease or potential for organ failure or death. Glucocorticoids are quite effective as initial therapy for most forms of sarcoidosis. However, the toxicity associated with long-term treatment often leads to the use of alternative treatments. These include cytotoxic agents such as methotrexate, biologic agents such as the antitumor necrosis factor antibody infliximab, and other anti-inflammatory drugs such as hydroxychloroquine. In some cases, anti-inflammatory drugs may not help. Examples include pulmonary hypertension and fibrosis. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25007090     DOI: 10.1055/s-0034-1376401

Source DB:  PubMed          Journal:  Semin Respir Crit Care Med        ISSN: 1069-3424            Impact factor:   3.119


  6 in total

1.  Risk of gastrointestinal events among patients with sarcoidosis: a population-based study 1976-2013.

Authors:  Patompong Ungprasert; Cynthia S Crowson; Eric L Matteson
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

Review 2.  New molecular targets for the treatment of sarcoidosis.

Authors:  Jared Chiarchiaro; Bill B Chen; Kevin F Gibson
Journal:  Curr Opin Pulm Med       Date:  2016-09       Impact factor: 3.155

Review 3.  Cough in Sarcoidosis.

Authors:  Timothy Tully; Surinder S Birring
Journal:  Lung       Date:  2015-09-09       Impact factor: 2.584

4.  Impaired survival of regulatory T cells in pulmonary sarcoidosis.

Authors:  Caroline E Broos; Menno van Nimwegen; Alex Kleinjan; Bregje ten Berge; Femke Muskens; Johannes C C M in 't Veen; Jouke T Annema; Bart N Lambrecht; Henk C Hoogsteden; Rudi W Hendriks; Mirjam Kool; Bernt van den Blink
Journal:  Respir Res       Date:  2015-09-16

5.  Autoimmunity and autoinflammation: A systems view on signaling pathway dysregulation profiles.

Authors:  Arsen Arakelyan; Lilit Nersisyan; David Poghosyan; Lusine Khondkaryan; Anna Hakobyan; Henry Löffler-Wirth; Evie Melanitou; Hans Binder
Journal:  PLoS One       Date:  2017-11-03       Impact factor: 3.240

6.  ProKaSaRe Study Protocol: A Prospective Multicenter Study of Pulmonary Rehabilitation of Patients With Sarcoidosis.

Authors:  Heidrun Lingner; Anika Großhennig; Kathrin Flunkert; Heike Buhr-Schinner; Rolf Heitmann; Ulrich Tönnesmann; Jochen van der Meyden; Konrad Schultz
Journal:  JMIR Res Protoc       Date:  2015-12-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.